drugset / Trial / NCT00334321

Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients

NCT00334321 ↗

Phase 1 Completed 65 enrolled Washington University School of Medicine
NaSingle-groupOpen-labelTreatment

Summary

This study is evaluating the feasibility of using helical tomotherapy to deliver IMRT in post-hysterectomy endometrial cancer patients receiving adjuvant radiotherapy.

Timeline

Start
2006-04
Primary completion
2011-04
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule 6 unknown Intravenous
Subject Paclitaxel Small molecule 175 mg/m2 Intravenous

Indications